Houman Ashrafian
Directeur Technique/Scientifique/R&D chez SANOFI
Provenance du réseau au premier degré de Houman Ashrafian
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
University of Oxford
570
| College/University | Other Consumer Services | 570 |
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London.
38
| Holding Company | Investment Managers | 38 |
35
| Public Company | Biotechnology | 35 |
SV Health Managers LLP
 SV Health Managers LLP Investment ManagersFinance SV Health Managers LLP (SVHM) is the investment management subsidiary of SV Life Sciences Advisers LLP in the UK. Established in 2005, the firm was formerly known as SV Life Sciences Managers LLP and changed their name to SV Health Managers LLP in 2017. Based in London, the firm manages the International Biotechnology Trust plc (LSE: IBT), an investment trust vehicle listed on the London Stock Exchange into which corporate and private investors may invest.
6
| Subsidiary | Investment Managers | 6 |
Zarodex Therapeutics Ltd.
 Zarodex Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Zarodex Therapeutics Ltd. engages in the research and experimental development on biotechnology. The company was founded on July 26, 2017 and is headquartered in London, the United Kingdom.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
Cellinta Ltd.
 Cellinta Ltd. Investment ManagersFinance Cellinta Ltd. operates as a biotechnology firm. The company was founded on August 16, 2019 and is headquartered in Reading, the United Kingdom.
2
| Holding Company | Investment Managers | 2 |
Cybele Therapeutics Ltd.
 Cybele Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Cybele Therapeutics Ltd. engages in research and experimental development on biotechnology. The company was founded on August 23, 2019 and is headquartered in Reading, the United Kingdom.
2
| Holding Company | Miscellaneous Commercial Services | 2 |
Weatherden Ltd.
 Weatherden Ltd. BiotechnologyHealth Technology Weatherden Ltd. is a pioneering clinical development consulting group based in London, UK. The British company specializes in scientific strategy, translational medicine, clinical development, diligence preparation, and support for M & A. Weatherden focuses on de-risking programs early and optimizing clinical, regulatory, and commercial pathways to bring life-changing medicines to patients. With over 750 years of combined industry experience, they are dedicated to improving the chances for breakthrough therapies to address unmet clinical needs. The private company, founded by Duncan McHale and Houman Ashrafian, provides trusted advice to biopharma, funds, startups, spin-outs, and nonprofits. Emma Tinsley has been the CEO of the company since 2017.
2
| Private Company | Biotechnology | 2 |
Ervaxx Ltd.
 Ervaxx Ltd. Pharmaceuticals: MajorHealth Technology Ervaxx Ltd. is a British company that pioneers the use of dark antigens to deliver targeted immunotherapies for treating and preventing cancer. The company was founded in 2016 by George Kassiotis, Drew M. Pardoll and is based in London, UK. The company's powerful, proprietary edapt platform has been developed to discover and validate dark antigens providing an in-depth assessment of candidate antigens on primary tumor cells along with their immunogenic potential. Ervaxx is advancing a pipeline of T cell receptor-based therapies, off-the-shelf cancer vaccines, and other immunotherapies leveraging these insights into the role of dark antigens in cancer.
2
| Holding Company | Pharmaceuticals: Major | 2 |
HMBL Ltd.
1
| Extinct | Miscellaneous Commercial Services | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Houman Ashrafian via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | Investment Trusts/Mutual Funds | Chief Investment Officer Director of Finance/CFO | |
| DANONE | Food: Meat/Fish/Dairy | Director/Board Member Chairman | |
| CAPGEMINI SE | Information Technology Services | Director/Board Member Director of Finance/CFO | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal | |
Inter-American Development Bank
 Inter-American Development Bank SupranationalGovernment Inter-American Development Bank engages in the provision of development financing to the Latin American and the Caribbean region. Its activities include provision of loans, grants, and technical assistance; and conducts extensive research. It provides services to the central governments, provinces, municipalities, private firms, and non-governmental organizations. The company was founded in 1959 and is headquartered in Washington, DC. | Supranational | Director/Board Member | |
Abide Therapeutics, Inc.
 Abide Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA. | Pharmaceuticals: Other | Director/Board Member | |
| SOCIÉTÉ GÉNÉRALE | Regional Banks | Chief Executive Officer Corporate Officer/Principal | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Corporate Officer/Principal Masters Business Admin | |
| Stanford University | College/University | Graduate Degree Masters Business Admin | |
| L'ORÉAL | Household/Personal Care | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Capgemini Technology Services India Ltd.
 Capgemini Technology Services India Ltd. Information Technology ServicesTechnology Services Capgemini Technology Services India Ltd. provides information technology and business process outsourcing services. It provides customized and packaged application development, application maintenance outsourcing, business intelligence services and application re-engineering through offshore development centers. The company was founded on December 27, 1993 and is headquartered in Pune, India. | Information Technology Services | Director/Board Member Director of Finance/CFO | |
| Imperial College London | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
SV Health Investors LLC
 SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| University of London | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
ESBATech, a Novartis Co. GmbH
 ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Analyst Private Equity Investor | |
| University of Aarhus | College/University | Undergraduate Degree Corporate Officer/Principal | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | General Counsel Chief Executive Officer | |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Karus Therapeutics Ltd.
 Karus Therapeutics Ltd. BiotechnologyHealth Technology Karus Therapeutics Ltd. provides therapies for treatment of cancer and inflammatory diseases. It offers HDAC6 and PI3K inhibitors for the treatment of cancer. The firm’s products in pipeline include KA-2237, KAR4000 Series and KAR3000 Series for the treatment of chronic inflammation, haematological malignancies, and solid tumours. The company was founded in July 2005 by Arasu Ganesan, Graham Keith Packham and Paul Townsend and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
| University of Copenhagen | College/University | Doctorate Degree Corporate Officer/Principal | |
| University of Utrecht | College/University | Corporate Officer/Principal Undergraduate Degree | |
| Ecole Polytechnique | College/University | Undergraduate Degree Director/Board Member | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin | |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
American Academy of Arts & Sciences
 American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| King's College London | College/University | Undergraduate Degree Graduate Degree | |
| The University of Texas Southwestern Medical Center | College/University | Corporate Officer/Principal | |
Cell Medica Switzerland AG
 Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Capgemini Service SAS
 Capgemini Service SAS Data Processing ServicesTechnology Services Capgemini Service SAS provides, technology and outsourcing services. The company was founded in 1965 and is headquartered in Paris, France. | Data Processing Services | Director/Board Member Director/Board Member | |
Capgemini Italia SpA
 Capgemini Italia SpA Miscellaneous Commercial ServicesCommercial Services Capgemini Italia SpA provides consultancy and technology services. It offers artificial intelligence, business operations, technology and cloud services. The firm serves automotive, insurance, banking, and telecom sectors. The company was founded by Serge Kampf in 1967 and is headquartered in Rome, Italy. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
The Private Sector Organisation of Jamaica
 The Private Sector Organisation of Jamaica Miscellaneous Commercial ServicesCommercial Services The Private Sector Organisation of Jamaica (PSOJ) is a national organization of private sector associations, companies, and individuals working together to promote a competitive and productive private sector. The PSOJ is based in Kingston, Jamaica, and Jennifer E. McDonald has been the CEO of the private company since 2018. The PSOJ provides guidance for COVID-19 measures and protocols, sexual harassment, and public safety updates. The organization also offers resources and publications, including an annual report and a quarterly newsletter. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Radius Communications (Ireland) Ltd.
 Radius Communications (Ireland) Ltd. Wholesale DistributorsDistribution Services Part of Facey Europe Ltd., Radius Communications (Ireland) Ltd. is a leading value-added distribution and Irish services company in Ireland. Radius Communications (Ireland is based in Bray, IE and provides distribution services to FMCG businesses in Ireland. The company specializes in three principal lines of business\: Consumer Distribution, Business Solutions/IT Distribution and Services, and Telecom Distribution and Service. | Wholesale Distributors | Director/Board Member | |
Circuit Therapeutics, Inc.
 Circuit Therapeutics, Inc. Medical/Nursing ServicesHealth Services Circuit Therapeutics, Inc. provides therapy and health care services. It specializes in optogenetics, gene therapy, neuromodulation and drug discovery services. The company was founded by Karl Deisseroth, Rob Malenka, Scott Delp, Thomas Sudhof and Karoly Nikolich and is headquartered in Menlo Park, CA. | Medical/Nursing Services | Founder | |
Facey Group Ltd.
 Facey Group Ltd. Food DistributorsDistribution Services Facey Group Ltd. engages in the distribution of food, pharmaceutical, telecom, and technology services. The company was founded in 1930 and is headquartered in St. Michael, Barbados. | Food Distributors | Director/Board Member | |
The World Bank (Research)
 The World Bank (Research) Investment ManagersFinance The World Bank (Research) (World Bank-Research) is the investment research division of The World Bank, an international financial institution headquartered in Washington, DC. It provides loans and grants to the governments of low- and middle-income countries for the purpose of pursuing capital projects. World Bank-Research provides research to developing nations to aid economic advancement. | Investment Managers | Economist Economist | |
SV Health Investors UK Ltd.
 SV Health Investors UK Ltd. Financial ConglomeratesFinance Part of SV Health Investors LLP, SV Health Investors UK Ltd. is a company that provides investment services. The company is based in London, UK and was founded in 2004. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Neucyte, Inc.
 Neucyte, Inc. Miscellaneous Commercial ServicesCommercial Services Neucyte, Inc. operates as bio technology company focusing on neurological diseases. The firm specializes in drug discovery process by using cell based target-identification and drug-discovery platforms. The company was founded by Daniel Haag, Thomas C. Sudhof, Jonathan Davila, and Tao Huang in 2015 and is headquartered in Mountain View, CA. | Miscellaneous Commercial Services | Founder | |
Sitryx Therapeutics Ltd.
 Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
Tiaki Therapeutics, Inc.
 Tiaki Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tiaki Therapeutics, Inc. develops novel therapeutics for Alzheimer's disease. The company was founded by Barbara Tate and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Founder | |
Loqus23 Therapeutics Ltd.
 Loqus23 Therapeutics Ltd. BiotechnologyHealth Technology Loqus23 Therapeutics Ltd.engages in research and development of biotechnology. The company was founded on March 29, 2019 and is headquartered in in Reading, the United Kingdom. | Biotechnology | Director/Board Member Chief Executive Officer | |
Eyebiotech Ltd.
 Eyebiotech Ltd. Pharmaceuticals: MajorHealth Technology Eyebiotech Ltd. develops new generation of therapies for eye diseases. The British company was founded in 2021 by David R. Guyer, Anthony P. Adamis. David R. Guyer has been the CEO since 2021. | Pharmaceuticals: Major | Director/Board Member Chairman |
Statistiques
Internationale
| Etats-Unis | 23 |
| Royaume-Uni | 11 |
| France | 8 |
| Danemark | 4 |
| Suisse | 3 |
Sectorielle
| Consumer Services | 14 |
| Health Technology | 14 |
| Commercial Services | 9 |
| Finance | 7 |
| Technology Services | 4 |
Opérationnelle
| Director/Board Member | 357 |
| Corporate Officer/Principal | 158 |
| Chairman | 84 |
| Undergraduate Degree | 62 |
| Chief Executive Officer | 53 |
Relations les plus connectées
| Insiders | |
|---|---|
| Gilles Schnepp | 60 |
| Michael Ross | 44 |
| Kate Bingham | 31 |
| Carole Ferrand | 30 |
| Patrick Kron | 28 |
| Nigel L. Clarke | 28 |
| Fabienne Lecorvaisier | 27 |
| Mark Carney | 25 |
| Thomas C. Südhof | 24 |
| Lise Kingo | 23 |
| Diane D. Souza | 21 |
| Stephen Davies | 18 |
| Ruth McKernan | 16 |
| Allan W. May | 16 |
| John Lee Allen | 16 |
- Bourse
- Insiders
- Houman Ashrafian
- Connexions Sociétés